What is the minimum investment required for PCD Pharma Franchise?

The minimum investment typically ranges from ₹2–5 lakhs, depending on territory size, product selection and initial stock planning. Our team will help structure this based on your goals.

What documents are required to become a franchise partner?

You will need a valid Drug License, GST registration and basic KYC documents. Our team will guide you through every step of the documentation process.

What kind of support and training do you provide?

We provide product training, sales guidance, marketing materials, doctor coverage strategies, and ongoing business support through dedicated account managers.

How are territories allocated and protected?

Territories are allocated based on mutual agreement and market mapping. We offer genuine monopoly rights with clear documentation to avoid internal competition.

What is the expected profit margin and ROI timeline?

Average profit margins range from 25–30%, with typical ROI timelines between 12–18 months, depending on your execution and territory potential.

How do you ensure product quality and compliance?

All products are manufactured in WHO-GMP certified facilities with 100% quality testing, robust documentation and DCGI approvals as applicable.

What is the delivery timeline and process?

Dispatch timelines depend on order size and location, but we maintain a strong track record of timely delivery across India with proper packaging and logistics partners.

Vials

Zami-500

Amikacin-500mg Inj

Pack: SINGLE
Format: With Carton

MRP₹85.00

A high-strength, broad-spectrum aminoglycoside antibiotic injection formulated for the intensive management of severe and life-threatening bacterial infections. ZAMI-500 delivers a concentrated 500mg dose of Amikacin to provide rapid bactericidal action against multi-drug resistant Gram-negative pathogens.

About The Product

Key Benefits

Advanced Bactericidal Action

Amikacin 500mg works by irreversibly binding to the bacterial 30S ribosomal subunit. This action causes a misreading of the genetic code, halting essential protein synthesis and leading to the rapid destruction of the bacterial cell.

Superior Resistance Profile

Designed to withstand degradation by aminoglycoside-inactivating enzymes, Amikacin remains effective where other antibiotics may fail. It is a vital therapeutic choice for treating resistant strains of Pseudomonas, E. coli, and Klebsiella.

High-Concentration Systemic Delivery

The 500mg injectable format ensures immediate and high peak plasma concentrations. This allows for deep tissue penetration, making it highly effective for treating infections in the lungs, bones, and abdominal cavity.

Targeteddd Gram-Negative Management

This formulation is specifically potent against serious aerobic Gram-negative infections, including those that are hospital-acquired or associated with post-surgical complications and compromised immune systems.

Synergistic Treatment Potential

ZAMI-500 is often used in combination with beta-lactam antibiotics to provide a dual-pathway attack against complex mixed infections, enhancing the overall clinical success rate in critical care settings.

Precision Critical Care Dosing

The 500mg strength is the gold standard for adult dosing in severe clinical scenarios, allowing for effective once-daily or multi-dose regimens tailored to the patient’s renal function and infection severity.

Indication Severe Septicemia, Complicated Intra-abdominal Infections, Nosocomial Respiratory Tract Infections, Complicated Urinary Tract Infections (UTI), Severe Skin and Soft Tissue Infections, Post-Surgical Bacterial Prophylaxis.

Indications

Severe Septicemia
Complicated Intra-abdominal Infections
Nosocomial Respiratory Tract Infections
Complicated Urinary Tract Infections (UTI)
Severe Skin and Soft Tissue Infections
Post-Surgical Bacterial Prophylaxis.

Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.

Zami-500